Injective is a Layer 1 blockchain built using the Cosmos SDK and Tendermint PoS consensus with the core function of helping financial apps be more interoperable between blockchains.
Built by Eric Chen (CEO) and Albert Chon (CTO) in 2018, the INJ coin has raised over $56m, including a private $10m investment from Mark Cuban. The founders told TechCrunch that they value high-profile investors with value to add rather than having larger amounts of capital to play with.
Injective offers various pre-built features, including a decentralized order book that allows developers to build complex apps with open and interoperable smart contracts, as well as its own decentralized ERC-20 token bridge to support native Ethereum-based assets within the Injective ecosystem. The interoperability already facilitates transactions between Ethereum, Moonbeam, CosmosHub, and also Wormhole-integrated L1s like Solana, Avalanche, Polygon, and BSC.
The original mission of Injective was to develop a decentralized infrastructure that would support some centralized instruments, therefore enabling cross-chain futures, options, and swaps. So far, the most successful demonstration of this is Helix, a DEX that currently offers 29 different market pairs.
We’ll explore everything you need to know about Injective in this article.